Related Experiment Video
Updated: Aug 14, 2026
10:48
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
10.1K
18F-fluorothymidine PET imaging in gliomas: an update
Alexandra Nikaki1,2, George Angelidis2, Roxani Efthimiadou3
1Department of Clinical Physiology, KHSHP, 20 Ahvenistontie Str., 13530, Hämeenlinna, Finland.
Annals of Nuclear Medicine
|June 15, 2017
Summary
Radiolabeled fluorothymidine-positron emission tomography (FLT-PET) offers improved brain tumor evaluation, aiding in diagnosis, prognosis, and monitoring treatment response, especially when MRI is limited.
Area of Science:
- Neuro-oncology
- Nuclear Medicine
- Radiopharmaceuticals
Background:
- Brain neoplasms exhibit varied grades, impacting disease course and prognosis.
- Magnetic resonance imaging (MRI) is standard for central nervous system tumors but has limitations, particularly after prior treatments.
- Positron emission tomography (PET) with novel radiopharmaceuticals enhances brain tumor investigation and patient management.
Purpose of the Study:
- To review the utility of radiolabeled fluorothymidine (FLT) imaging in evaluating brain tumors.
- To explore FLT-PET's role in differentiating tumor grades, assessing prognosis, and monitoring treatment.
- To discuss the application of FLT-PET in detecting disease recurrence and relevant imaging parameters.
Main Methods:
- Review of existing literature on FLT-PET imaging in brain tumors.
- Discussion of FLT-PET's capabilities in characterizing tumor differentiation.
- Analysis of semi-quantitative and kinetic parameters derived from FLT-PET scans.
Main Results:
- FLT-PET imaging can depict both well- and poorly differentiated brain lesions.
- FLT-PET aids in assessing patient prognosis and response to therapy.
- FLT-PET is valuable for recognizing disease recurrence.
Conclusions:
- FLT-PET imaging presents a significant potential contribution to the evaluation of brain tumors.
- This technique assists in clinical decision-making by providing crucial information on tumor biology and response.
- Further investigation into FLT-PET parameters can optimize its use in neuro-oncology.
Related Concept Videos
01:29Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET